NeuroDex
Biotechnology ResearchMassachusetts, United States11-50 Employees
NeuroDex is a biotechnology company focused on developing blood-based diagnostics for neurodegenerative disorders. Its core approach centers on isolating neuronal-derived exosomes from blood and analyzing them to support neurological research and development, with collaborations that broaden access to its platform for advancing studies in the field. Based in Natick, Massachusetts, the company positions itself within the biotechnology research sector by offering biomarkers and an exosome-based broad biomarker program aimed at identifying neurodegenerative conditions and differentiating related dementias. The business serves researchers and collaborators seeking objective, minimally invasive insights into neurological disease processes, including Parkinson’s disease and other synucleinopathies, through its extracellular vesicle–led assays. A recent development includes ongoing work announced in 2026 around measuring amyloid fibril characteristics as part of biomarker efforts, reflecting a continued focus on blood-based indicators for neurodegenerative disorders.
1-888-653-2347 
support@leadiq.com 
